全國(guó)服務(wù)咨詢熱線：
13761418683
13761418683
簡(jiǎn)要描述：CNQX 115066-14-3 CNQX (FG9065) 是高效的 AMPA/kainate 受體拮抗劑。
產(chǎn)品型號(hào)：abs812835廠商性質(zhì)：生產(chǎn)廠家更新時(shí)間：2026-02-26訪 問 量：2704產(chǎn)品分類
Product Category詳細(xì)介紹
| 品牌 | absin | CAS | 115066-14-3 |
|---|---|---|---|
| 分子式 | C9H4N4O4 | 純度 | ＞98% |
| 分子量 | 232.15 | 貨號(hào) | abs812835 |
| 規(guī)格 | 10mg | 供貨周期 | 現(xiàn)貨 |
| 主要用途 | 是高效的 AMPA/kainate 受體拮抗劑。 | 應(yīng)用領(lǐng)域 | 化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合 |
CNQX 115066-14-3
| 產(chǎn)品描述 | |
| 描述 | CNQX (FG9065) 是高效的 AMPA/kainate 受體拮抗劑。 |
| 純度 | ＞98% |
| 儲(chǔ)存/保存方法 | Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 別名 | FG9065 |
| 可溶性/溶解性 | DMSO: ≥30 mg/mL |
| 生物活性 | |
| 靶點(diǎn) | iGluR |
| In vitro(體外研究) | In rat hippocampal slices bathed in Mg2+-free medium, 10 μM CNQX reversibly blocks responses to a-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA), quisqualate and kainate but not NMDA. Superfusion of hippocampal slices with 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 2-5 μM) reversibly blocks the Schaffer collateral and mossy fibre excitatory postsynaptic potential (EPSP), while sparing the fast and slow GABA-mediated inhibition. CNQX (1-5 μM) produces a selective and dose-dependent reduction in the amplitude of the monosynaptic component of the DR-VRR recorded from lumbar spinal segments. CNQX-mediated depolarizations are mediated by AMPAR but not kainate receptors in TRN neurons. |
| In vivo(體內(nèi)研究) | The bilateral infusion of CNQX (0.5 or 1.25 μg) into the amygdala or dorsal hippocampus 10 min prior to a retention test partially blocks the expression of stepdown inhibitory avoidance in rats 24 h after training. CNQX causes a complete blockade at a dose of 0.5 μg. |
| 參考文獻(xiàn) | |
| 參考文獻(xiàn) | [1]. Blake JF, et al. CNQX blocks acidic amino acid induced depolarizations and synaptic components mediated by non-NMDA receptors in rathippocampal slices. Neurosci Lett. 1988 Jun 29;89(2):182-6. [2]. Neuman RS, et al. Blockade of excitatory synaptic transmission by 6-cyano-7-nitroquinoxaline-2,3-dione(CNQX) in the hippocampus in vitro. Neurosci Lett. 1988 Sep 23;92(1):64-8. [3]. Alford S, et al. CNQX and DNQX block non-NMDA synaptic transmission but not NMDA-evoked locomotion in lamprey spinal cord. Brain Res. 1990 Jan 8;506(2):297-302. [4]. Lee SH, et al. Selective excitatory actions of DNQX and CNQX in rat thalamic neurons. J Neurophysiol. 2010 Apr;103(4):1728-34. [5]. Kim M, et al. Infusion of the non-NMDA receptor antagonist CNQX into the amygdala blocks the expression of fear-potentiated startle. Behav Neural Biol. 1993 Jan;59(1):5-8. |
| 研究領(lǐng)域 | |
| 研究領(lǐng)域 | Neuroscience Drug DiscoverySmall Molecule DrugLead Compound Discovery |
產(chǎn)品咨詢
地址：上海市浦東新區(qū)新浩路58號(hào)申江科創(chuàng)園18棟
郵箱：fengmj@univ-bio.com
傳真：